GMI vs HbA1c: What the Glucose Management Indicator Means

If you use a CGM, you've probably seen a figure called GMI — the Glucose Management Indicator. It looks like an A1c and is often read like one, but it's an estimate derived from your sensor's average glucose. Understanding what it is (and isn't) explains why your GMI and a lab HbA1c can disagree — and why that gap is usually normal.

What GMI is

GMI is an estimate of laboratory HbA1c calculated from CGM data. Instead of measuring glycated hemoglobin in a blood sample, it takes the average (mean) glucose your CGM recorded over a stretch of time and converts it to an A1c-like percentage. It was introduced by Bergenstal and colleagues in a 2018 Diabetes Care paper, partly to replace an older term ("estimated A1c") that some found confusing.

The recommended basis is at least about two weeks of CGM data with sufficient sensor wear, so the average is representative. GMI is a standard part of the ambulatory glucose profile report and sits alongside metrics like time in range and glucose variability.

The formula

The published Bergenstal formula, for mean glucose expressed in mg/dL, is:

As a worked example, a mean glucose of 154 mg/dL gives roughly 3.31 + (0.02392 × 154) ≈ 7.0%. You don't need to do the arithmetic by hand — our HbA1c calculator and time-in-range calculator can help you work with these numbers. The key point is that GMI is a direct function of your average glucose: nothing else feeds into it.

Why GMI and lab HbA1c can differ

Here's the crux. GMI and HbA1c are related but not identical measures, so it's normal for them to differ by a few tenths of a percent — and sometimes more. Several reasons explain the gap:

• Different windows. GMI reflects your CGM average over the last couple of weeks. HbA1c reflects glycated hemoglobin over roughly the prior two to three months, weighted toward the more recent weeks.
• Different biology. HbA1c depends on how glucose attaches to hemoglobin and on red blood cell lifespan, which varies between people. Conditions like anemia, certain hemoglobin variants, pregnancy, or recent blood loss can shift HbA1c independently of average glucose.
• Data quality. Short wear time, gaps in the CGM trace, or an unrepresentative two weeks can pull GMI away from the longer-term reality.

Bergenstal and colleagues emphasised this very point: because individuals glycate hemoglobin at different rates, GMI and measured A1c will not always match, and GMI is meant to complement — not replace — a lab HbA1c. Our HbA1c vs CGM article digs further into how averages and continuous data tell different parts of the story.

What a gap suggests

A small difference is unremarkable. A larger or persistent gap is a useful prompt — not a diagnosis. Depending on direction and context, a clinician might consider:

• Whether red-cell factors (anemia, hemoglobin variants, recent transfusion) are affecting the lab HbA1c.
• Whether glucose control has changed recently, so the two-week CGM window and the three-month HbA1c are describing different periods.
• Whether the CGM data was sufficient — enough days, minimal gaps — to give a trustworthy average.

The practical takeaway: use GMI as a convenient, frequent check-in on recent average glucose, and use lab HbA1c as the longer-term, standardised reference. When they disagree meaningfully, that's information to bring to a clinician. Software like Endobits helps clinicians interpret CGM metrics like GMI as decision support, always alongside standard testing rather than in place of it. For definitions of these terms, see our glossary.

Sources

Bergenstal et al., 2018 — Glucose Management Indicator (Diabetes Care) · American Diabetes Association — Understanding A1C · NIH / NIDDK — The A1C Test & Diabetes

Related: HbA1c vs CGM · What is time in range? · HbA1c calculator